» Articles » PMID: 35784580

Influence of Dietary Salt Intake on T2D Treatment

Overview
Specialty Endocrinology
Date 2022 Jul 5
PMID 35784580
Authors
Affiliations
Soon will be listed here.
Abstract

Backgrounds: To what extent patients undergoing long-term T2D treatment are affected by dietary salt intake has not been completely investigated.

Objectives: We aimed to investigate the influence of dietary salt intakes on T2D treatment, including glucose-lowering effect and indices related to T2D progression.

Methods: The study recruited 1090 patients with T2D at Ningbo City First Hospital from January 1, 2018, to December 30, 2021. We compared their one-year follow-up outcomes in terms of fasting blood glucose (FBG), glycated hemoglobin (HbA1c), blood pressure, obesity, and prevalence of retinopathy and neuropathy among groups with different dietary salt intakes.

Results: The 1090 patients consisted of 287(26.3%) decreasing-, 190(17.4%) increasing-, 175(16.0%) steadily low-, 243(22.3%) steadily medium-, and 195(17.9%) steadily high-dietary salt intake patients. Compared to increasing-, steadily medium-, and steadily high-dietary salt intake patients, decreasing and steadily low salt intake led to lower baseline FBG, HbA1c, systolic blood pressure (SBP), BMI, and visceral fat area (VFA) (all p<0.05), to a larger decrease in FBG, HbA1c, SBP, BMI, and VFA after one-year treatment (all p<0.05), as well as to a slightly lower prevalence of retinopathy and a significantly lower prevalence of neuropathy. The steadily low salt patients had lower urine albumin/creatinine ratio (UAR) both at baseline and after treatment. Notably, the fasting insulin in the steadily low salt group was higher than the remaining groups after treatment (p<0.01).

Conclusions: The present study concludes that lowered dietary salt intake benefits T2D treatment in multiple aspects, including main treatment targets such as FBG and HbA1c, and indices reflecting potential complications of T2D, including BMI, VFA, SBP, UAR, retinopathy, and neuropathy.

Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03811470.

Citing Articles

High-Salt Diet Accelerates Neuron Loss and Anxiety in Mice Through Serpina3n.

Ma K, Zhang C, Zhang H, An C, Li G, Cheng L Int J Mol Sci. 2024; 25(21).

PMID: 39519278 PMC: 11546851. DOI: 10.3390/ijms252111731.


Intermuscular adipose tissue accumulation is associated with higher tissue sodium in healthy individuals.

Ertuglu L, Sahinoz M, Alsouqi A, Deger S, Guide A, Pike M Physiol Rep. 2024; 12(13):e16127.

PMID: 38960895 PMC: 11222016. DOI: 10.14814/phy2.16127.

References
1.
Xie J, Shapiro A, Shapiro J . The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?. Front Endocrinol (Lausanne). 2014; 5:97. PMC: 4101451. DOI: 10.3389/fendo.2014.00097. View

2.
Rahmoune H, Thompson P, Ward J, Smith C, Hong G, Brown J . Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005; 54(12):3427-34. DOI: 10.2337/diabetes.54.12.3427. View

3.
Vujosevic S, Aldington S, Silva P, Hernandez C, Scanlon P, Peto T . Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020; 8(4):337-347. DOI: 10.1016/S2213-8587(19)30411-5. View

4.
Li Q, Fang W, Hu F, Zhou X, Cheng Y, Jiang C . A high-salt diet aggravates retinal ischaemia/reperfusion injury. Exp Eye Res. 2019; 188:107784. DOI: 10.1016/j.exer.2019.107784. View

5.
Patel S, Cobb P, Saydah S, Zhang X, de Jesus J, Cogswell M . Dietary sodium reduction does not affect circulating glucose concentrations in fasting children or adults: findings from a systematic review and meta-analysis. J Nutr. 2015; 145(3):505-13. PMC: 4336531. DOI: 10.3945/jn.114.195982. View